SciELO - Scientific Electronic Library Online

 
vol.21 número4Alergia a beta-lactámicosSífilis congénita: Optimizando el diagnóstico en 191 neonatos de madres seropositivas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista chilena de infectología

versión impresa ISSN 0716-1018

Resumen

BLAMEY D., Rodrigo. Experience and dealing with toxicities in treatments with alternative nucleoside analogues of reverse transcriptase inhibitors schedules. Rev. chil. infectol. [online]. 2004, vol.21, n.4, pp.299-306. ISSN 0716-1018.  http://dx.doi.org/10.4067/S0716-10182004000400003.

The mortality related to AIDS became under control, at the last decade, after HAART was introduced. Nonetheless, soon after the first NRTI was developed, multiple side effects were described. These side effects are often the main shortcoming for HIV infected patients with antiretroviral therapy by now, since other threats like opportunistic infections are rare and HIV infection is a more chronic disease. As a class side effect, mitochondrial toxicity can express from an asymptomatic hiperlactacidemia up to a lifethreatening lactic acidosis. Other NRTI side effects are lipodystrophy (a complex morphometabolic syndrome), peripheral neuropathy, pancreatitis and hypersensitivity reaction with abacavir. This review explores pathophysiology, clinical features and therapeutic options for each one of the major side effects of NRTI, except AZT.

Palabras clave : AIDS; Antiretroviral therapy; Toxicity; Reverse transcriptase inhibitors.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons